Why the study?
Is sleep-disordered breathing associated with visceral adiposity and insulin resistance in obese adolescents?
Is sleep-disordered breathing associated with visceral adiposity and insulin resistance in obese adolescents?
In obese adolescents, sleep-disordered breathing is strongly associated with visceral adiposity and insulin resistance, independent of BMI.
Answers are grounded in this paper and cite their sources.
Association in obese adolescents does not imply causation; leaves open whether treating sleep-disordered breathing improves visceral adiposity or insulin resistance.
Sleep-disordered breathing is associated with obesity, insulin resistance, and the metabolic syndrome in adults. Similar data in children is limited and conflicting. This pilot study examined the relationships between sleep-disordered breathing, visceral adiposity, and cardiometabolic risk factors in obese adolescents. Twenty obese (body mass index ≥ 95(th) percentile), otherwise healthy adolescents (age 14.9 ± 2 years) underwent polysomnogram studies, fasting lipid profile and oral glucose tolerance tests, and measures of body composition (dual-energy X-ray absorptiometry) and visceral adiposity (abdominal computed tomography). The severity of sleep-disordered breathing (as measured by apnea-hypopnea index) was positively associated with visceral adipose tissue (r = 0.73, p < 0.001) but not with other measures of body composition. After controlling for body mass index, the severity of sleep-disordered breathing was positively associated with markers of insulin resistance (homeostasis model assessment and fasting insulin). Further study to allow for critical assessment of the relationships between sleep-disordered breathing and cardiometabolic risk factors in obese youth remains necessary.
No takes yet. Share an insight, caveat, or question.
Hannon et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: